Publications by authors named "Josh D Nelson"

Following CD4 receptor binding to the HIV-1 envelope spike (Env), the conserved N-heptad repeat (NHR) region of gp41 forms a coiled-coil that is a precursor to the fusion reaction. Although it has been a target of drug and vaccine design, there are few monoclonal antibody (mAb) tools with which to probe the antigenicity and immunogenicity specifically of the NHR coiled-coil. Here, we have rescued HIV-1-neutralizing anti-NHR mAbs from immune phage display libraries that were prepared (i) from b9 rabbits immunized with a previously described mimetic of the NHR coiled-coil, N35(CCG)-N13, and (ii) from an HIV-1 infected individual.

View Article and Find Full Text PDF

The membrane-proximal external region (MPER) of human immunodeficiency virus type 1 (HIV-1) gp41 bears the epitopes of two broadly neutralizing antibodies (Abs), 2F5 and 4E10, making it a target for vaccine design. A third Ab, Fab Z13, had previously been mapped to an epitope that overlaps those of 2F5 and 4E10 but only weakly neutralizes a limited set of primary isolates. Here, libraries of Fab Z13 variants displayed on phage were engineered and affinity selected against an MPER peptide and recombinant gp41.

View Article and Find Full Text PDF

The human immunodeficiency virus type 1 (HIV-1) neutralizing antibody 4E10 binds to a linear, highly conserved epitope within the membrane-proximal external region of the HIV-1 envelope glycoprotein gp41. We have delineated the peptide epitope of the broadly neutralizing 4E10 antibody to gp41 residues 671 to 683, using peptides with different lengths encompassing the previously suggested core epitope (NWFDIT). Peptide binding to the 4E10 antibody was assessed by competition enzyme-linked immunosorbent assay, and the K(d) values of selected peptides were determined using surface plasmon resonance.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Josh D Nelson"

  • - Josh D Nelson's research primarily focuses on the development and characterization of neutralizing antibodies against the HIV-1 envelope glycoprotein, particularly targeting the gp41 region, which plays a crucial role in the virus's fusion and infection processes.
  • - Key findings reveal that while some antibodies can moderately neutralize HIV-1 by targeting conserved regions of gp41, there exist non-neutralizing antibodies that also bind to mimetic structures of these epitopes, indicating a complex interaction that could inform vaccine design.
  • - His studies utilize advanced techniques like phage display and surface plasmon resonance to enhance the specificity and potency of these antibodies, contributing valuable insights into the mechanisms of HIV-1 neutralization and the optimization of therapeutic strategies.